Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many common genetic disorders of the blood can be identified in utero, either by fetal blood sampling, biochemical analysis of amniotic fluid cells or directly by studying DNA obtained from amniotic fluid cells or chorion biopsy. With the development of gene probes for most of the important genetic disorders of the blood there will be a gradual transition from fetal blood sampling and amniocentesis to chorion biopsy as the major approach to prenatal diagnosis of haematological disorders. Since the carrier states for many of these conditions can be identified at the antenatal clinic by a careful family history and a few relatively simple blood tests the outlook for prevention of many of the important genetic disorders of the blood is extremely promising.


Journal article


Clin Haematol

Publication Date





747 - 74